These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4063205)

  • 1. Demonstration of haemoglobin associated with isolated, purified spectrin from senescent human red cells.
    Snyder LM; Garver F; Liu SC; Leb L; Trainor J; Fortier NL
    Br J Haematol; 1985 Nov; 61(3):415-9. PubMed ID: 4063205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrin degradation in intact red blood cells by phenylhydrazine.
    Arduini A; Stern A
    Biochem Pharmacol; 1985 Dec; 34(24):4283-9. PubMed ID: 4074388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irreversible spectrin-haemoglobin crosslinking in vivo: a marker for red cell senescence.
    Snyder LM; Leb L; Piotrowski J; Sauberman N; Liu SC; Fortier NL
    Br J Haematol; 1983 Mar; 53(3):379-84. PubMed ID: 6824583
    [No Abstract]   [Full Text] [Related]  

  • 4. Membrane proteins in senescent erythrocytes.
    Suzuki T; Dale GL
    Biochem J; 1989 Jan; 257(1):37-41. PubMed ID: 2522000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional analysis of spectrin from neonatal erythrocytes.
    Hajjar KA
    Biochim Biophys Acta; 1985 Mar; 827(3):460-5. PubMed ID: 3970945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cell-age specific antigen on senescent human red blood cells.
    Lutz HU
    Acta Biol Med Ger; 1981; 40(4-5):393-400. PubMed ID: 7315088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of abnormally [32P]-phosphorylated cyanogen bromide cleavage product of erythrocyte membrane spectrin in Duchenne muscular dystrophy.
    Roses AD; Shile PE; Herbstreith MH; Balakrishnan CV
    Neurology; 1981 Aug; 31(8):1026-30. PubMed ID: 7196515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of spectrin-free vesicles from human erythrocytes during ATP depletion. I. Characterization of spectrin-free vesicles.
    Lutz HU; Liu SC; Palek J
    J Cell Biol; 1977 Jun; 73(3):548-60. PubMed ID: 873988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties and characterization of vesicles released by young and old human red cells.
    Snyder LM; Fairbanks G; Trainor J; Fortier NL; Jacobs JB; Leb L
    Br J Haematol; 1985 Mar; 59(3):513-22. PubMed ID: 3970863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrin loss during in vitro red cell lysis.
    Kansu E; Krasnow SH; Ballas SK
    Biochim Biophys Acta; 1980 Feb; 596(1):18-27. PubMed ID: 6766318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of human erythrocyte spectrin by sodium dodecyl sulfate-polyacrylamide gel electrophoresis using pancreatic trypsin inhibitor (Kunitz) as an internal standard.
    Yoshida H; Takamatsu S; Satoh K; Kawamura Y; Imaizumi T; Teshiromori R; Kawauchi K
    Clin Chim Acta; 1991 May; 199(1):99-108. PubMed ID: 1718635
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemoglobins of inbred mice: differences in polymerization in the maturation of red blood cells.
    Strekalov AA; Novoseletskii AG
    Mol Biol; 1971; 5(1):17-24. PubMed ID: 5154798
    [No Abstract]   [Full Text] [Related]  

  • 13. Spectrin-haemoglobin crosslinkages associated with in vitro oxidant hypersensitivity in pathologic and artificially dehydrated red cells.
    Sauberman N; Fortier NL; Joshi W; Piotrowski J; Snyder LM
    Br J Haematol; 1983 May; 54(1):15-28. PubMed ID: 6849833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficient red-cell spectrin in severe, recessively inherited spherocytosis.
    Agre P; Orringer EP; Bennett V
    N Engl J Med; 1982 May; 306(19):1155-61. PubMed ID: 7070419
    [No Abstract]   [Full Text] [Related]  

  • 15. Reactions of the alkylating agent tris(2-chloroethyl)-amine with the erythrocyte membrane. Effects on shape changes of human erythrocytes and ghosts.
    Wildenauer DB; Reuther H; Remien J
    Biochim Biophys Acta; 1980 Dec; 603(1):101-16. PubMed ID: 7448181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin-spectrin interaction under oxidative conditions.
    Snyder LM; Fortier NL; Sauberman N; Leb L; Trainor J; Fairbanks G
    Prog Clin Biol Res; 1984; 159():227-42. PubMed ID: 6473463
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydrophobic labelling of spectrin in erythrocytes using arylisothiocyanates.
    Sikorski AF; Kuczek M; Nyczka Z; Kubiak ZJ
    Biomed Biochim Acta; 1987; 46(1):75-82. PubMed ID: 3579888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal content of brain spectrin-like protein in sph/sph mice.
    Casoria LA; Zagon IS; Bernstein SE; Shohet SB; McLaughlin PJ; Goodman SR
    Br J Haematol; 1984 Oct; 58(2):277-88. PubMed ID: 6383455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of modified bovine haemoglobin by molecular filtration and electrophoresis in gradient gels.
    Fortová H; Suttnar J; Kramlová M; Pristoupil TI
    J Chromatogr; 1986 May; 357(2):325-9. PubMed ID: 3711186
    [No Abstract]   [Full Text] [Related]  

  • 20. Band 3 is a target protein of spectrin's E2/E3 activity: implication for sickle cell disease and normal red blood cell aging.
    Chang TL; Cubillos FF; Kakhniashvili DG; Goodman SR
    Cell Mol Biol (Noisy-le-grand); 2004 Mar; 50(2):171-7. PubMed ID: 15095787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.